Erdheim-Chester病(ECD)腹部受累:MRI与CT影像表现及其与BRAFV600E突变的关联
这项前瞻性研究纳入61例ECD患者,由两位有经验的放射科医生独立评估MRI和CT,分析腹部受累表现及其与BRAFV600E突变的关联。肾周浸润最常见(67%),近端输尿管受累61%,肾窦受累56%,肾积水38%;肾上腺浸润48%。BRAFV600E突变与肾周浸润、肾窦受累、近端输尿管浸润、肾积水、肾上腺受累、肾动脉周围浸润、肾动脉鞘套或狭窄及其他主动脉分支鞘套存在显著关联。
要点
- 肾周浸润是ECD最常见的腹部表现(67%),其次为近端输尿管受累(61%)。
- BRAFV600E突变与肾周浸润、肾窦受累、近端输尿管浸润、肾积水及肾上腺受累均显著相关。
- 考虑到多项关联,原文建议在ECD患者中评估BRAFV600E突变状态。
核心结论
- 肾脏和血管结构是ECD患者最常受累的腹部器官,部分腹部影像表现与BRAFV600E突变存在显著正相关。
研究设计与样本
- 前瞻性研究,纳入61例ECD患者(46例男性),MRI和CT影像由两位有经验的放射科医生独立审阅;采用Fisher精确检验分析BRAFV600E突变与影像表现的关联,并计算比值比及95%置信区间。
关键影像表现/征象
- 肾周浸润为最常见表现(67%),其次为近端输尿管受累(61%)。
- 56%的病例浸润延伸至肾窦,38%引起肾积水。
- 肾上腺浸润见于48%的患者。
- 血管表现以肾动脉浸润(49%)和主动脉浸润(43%)最常见,其次为腹腔干、肠系膜上动脉或肠系膜下动脉鞘套(23%)。
诊断标准与关键数值
- BRAFV600E突变在可解读BRAF测序的患者中阳性率为53%。
- BRAFV600E突变与肾周浸润显著相关(p=0.003)。
- BRAFV600E突变与肾窦受累、近端输尿管浸润、肾积水、肾上腺受累及肾动脉鞘套或狭窄均显著相关(p<0.001)。
- BRAFV600E突变与主动脉周围浸润显著相关(p=0.03),与其他主动脉分支鞘套显著相关(p=0.04)。
临床应用与阅片要点
- 腹部影像在ECD管理中起关键作用。
- 原文建议在ECD患者中评估BRAFV600E突变状态。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To use magnetic resonance imaging (MRI) and computed tomography (CT) to define abdominal involvement in Erdheim-Chester disease (ECD), and to investigate the association between these findings and the BRAFV600E mutation.
METHODS: This prospective study was performed on 61 ECD patients (46 men). The MRI and CT imaging studies were reviewed independently by two experienced radiologists. The association between BRAFV600E mutation and imaging findings was analysed using Fisher's exact test, and odds ratios with 95% confidence intervals.
RESULTS: Perinephric infiltration was the most common finding (67%), followed by involvement of proximal ureters (61%). In 56% of cases, infiltration extended to the renal sinuses, and in 38% caused hydronephrosis. Adrenal gland infiltration was present in 48% of patients. Infiltration of renal artery (49%) and aorta (43%) were the most common vascular findings, followed by sheathing of celiac, superior mesenteric artery (SMA) or inferior mesenteric artery (IMA) (23%). The BRAFV600E mutation was positive in 53% of patients with interpretable BRAF sequencing. There was a statistically significant association between this mutation and perinephric infiltration (p = 0.003), renal sinus involvement (p < 0.001), infiltration of proximal ureters (p < 0.001), hydronephrosis (p < 0.001), adrenal gland involvement (p < 0.001), periaortic infiltration (p = 0.03), sheathing or stenosis of renal artery (p < 0.001) and sheathing of other aortic branches (p = 0.04).
CONCLUSIONS: Renal and vascular structures are the most commonly affected abdominal organs in ECD patients. Some of these findings have significant positive association with the BRAFV600E mutation.
KEY POINTS: • Abdominal imaging plays a crucial role in management of Erdheim-Chester disease. • Significant associations exist between BRAF V600E mutation and several abdominal imaging findings. • Considering several associations, evaluating BRAFV600E mutation status is recommended in ECD patients.
引用
- Nikpanah M, Kim L, Mirmomen SM, et al. Abdominal involvement in Erdheim-Chester disease (ECD): MRI and CT imaging findings and their association with BRAFV600E mutation. Eur Radiol. 2018. PMID: 29556768. doi:10.1007/s00330-018-5326-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。